|
NIPA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.883400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.596200E-01 |
| Normal-vs-Stage2 |
8.387600E-01 |
| Normal-vs-Stage3 |
8.348400E-01 |
| Normal-vs-Stage4 |
7.661200E-01 |
| Stage1-vs-Stage2 |
5.202600E-01 |
| Stage1-vs-Stage3 |
7.594200E-01 |
| Stage1-vs-Stage4 |
5.130400E-01 |
| Stage2-vs-Stage3 |
7.561200E-01 |
| Stage2-vs-Stage4 |
8.807200E-01 |
| Stage3-vs-Stage4 |
6.912600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.545400E-01 |
| Normal-vs-AfricanAmerican |
6.191400E-01 |
| Normal-vs-Asian |
3.894400E-01 |
| Caucasian-vs-AfricanAmerican |
6.662400E-01 |
| Caucasian-vs-Asian |
4.244000E-01 |
| AfricanAmerican-vs-Asian |
4.745200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.509200E-01 |
| Normal-vs-Female |
1.472240E-01 |
| Male-vs-Female |
2.032500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.547200E-01 |
| Normal-vs-Extreme_Weight |
3.510800E-01 |
| Normal-vs-Obese |
5.292000E-01 |
| Normal-vs-Extreme_Obese |
7.076000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.502000E-01 |
| Normal_Weight-vs-Obese |
2.809800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.540800E-01 |
| Extreme_Weight-vs-Obese |
1.989030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.301000E-01 |
| Obese-vs-Extreme_Obese |
5.745000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.368400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.442390E-01 |
| Normal-vs-Age(61-80Yrs) |
8.445700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.032000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.414000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.987600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.443600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.043200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.073810E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.437800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.118600E-01 |
| Normal-VS-Type2 PRCC |
2.587600E-01 |
| Normal-VS-KIRP CIMP |
9.488300E-02 |
| Normal-VS-Unclassified PRCC |
4.842600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.499810E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.328020E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.573000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.290400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.670800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.965800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.763740E-02 |
| Normal-vs-N1 |
8.555800E-01 |
| Normal-vs-N2 |
7.099800E-01 |
| N0-vs-N1 |
7.344200E-02 |
| N0-vs-N2 |
4.761800E-01 |
| N1-vs-N2 |
6.031000E-01 |
|
|
